p53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India

Cancer

Volumn 88, Issue 7, 2000, Pages 1565-1573

  Katiyar, Sanjay ^a,c   Dash, Bipin C ^b   Thakur, Varsha ^b   Guptan, Raj C ^b   Sarin, Shiv K ^b   Das, Bhudev C ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

^b G B PANT HOSPITAL   (India)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Aflatoxin B1; Hepatitis B surface antigen (HbsAg); Hepatitis B virus; Hepatocellular carcinoma; p53 mutation; Polymerase chain reaction (PCR); Single strand conformation polymorphism (SSCP)

Indexed keywords

AFLATOXIN; AMINO ACID; ARGININE; HEPATITIS B SURFACE ANTIGEN; PROLINE; PROTEIN P53; SERINE; VIRUS DNA; VIRUS ENVELOPE PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; MISSENSE MUTATION; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHILD; DNA MUTATIONAL ANALYSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXONS; FEMALE; GENES, P53; HEPATITIS B; HUMANS; INDIA; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTATION; MUTATION, MISSENSE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

EID: 0034177905     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000401)88:7<1565::AID-CNCR10>3.0.CO;2-9     Document Type: Article

References (57)

1. Van Rensberg SJ, Cook-Mozaffari P, Van Schalkwyk DJ, Van Der Watt JJ, Vincent TJ, Purchase IF, Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Br J Cancer 1985;51:713-26.
2. Okuda K, Fujimoto I, Urano Y. Changing incidence of hepatocellular carcinoma in Japan. Cancer Res 1987;47:4967-72.
3. Di Bisceglie AM, Rustgi VK, Hoofnagle JH, Dusheiko GM, Lortze M. Hepatocellular carcinoma. Ann Intern Med 1988; 108:390-401.
4. Parkin DM, Laara E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988;41:184-97.
5. Murakami Y, Hayashi K, Hirohashi S, Sekiya T. Aberrations of the tumour suppressor p53 and retinoblastoma genes in human hepatocellular carcinoma. Cancer Res 1991;51: 5520-5.
6. Lutwick LI. Relation between aflatoxins and hepatitis-B virus and hepatocellular carcinoma. Lancet 1979;i:755-7.
7. Kew MC. The hepatitis-B virus and hepatocellular carcinoma. Semin Liver Dis 1981;1:59-67.
8. Yeh FS, Yu MC, Mo CC, Luo S, Ton MJ, Henderson BE. Hepatitis B virus, aflatoxins and hepatocellular carcinoma in southern Guangxi, China. Cancer Res 1989;49:2506-9.
9. Harris CC. Chemical and physical carcinogenesis advances and perspectives for the 1990s. Cancer Res 1991;51(Suppl): 5023s-44s.
10. Tabor B. Tumour suppressor genes, growth factor genes and oncogenes in hepatitis B virus-associated hepatocellular carcinoma. J Med Virol 1994;42:357-65.
11. Wands JR, Blum HE. Primary hepatocellular carcinoma. N Engl J Med 1991;325:729-31.
12. Soini Y, Chia SC, Bennett WP, Groopman JD, Wang JS, De Benedetti VMG, et al. An aflatoxin-associated mutational hotpsot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico. Carcinogenesis 1996;17:1007-12.
13. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumour suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;55: 4855-78.
14. Lane DP. p53, gaurdian of the genome. Nature 1992;358: 15-6.
15. Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from Southern Africa. Nature 1991;350:429-31.
16. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in hepatocellular carcinomas. Nature 1991;350:427-8.
17. Oztruk M. p53 mutation in hepatocellular carcnoma after aflatoxin exposure. Lancet 1991;338:1356-9.
18. Teramoto T, Satonaka K, Kitazawa S, Fujimori T, Hayashi K, Maeda S. p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis. Cancer Res 1994;54:231-5.
19. 1 induces the transversions of G to T in codon 249 of the p53 tumour suppressor gene in hepatocytes. Proc Natl Acad Sci USA 1993;90:8586-90.
20. 1. Proc Natl Acad Sci USA 1983;80:2695-8.
21. Aguliar F, Harris CC, Sun T, Hollstein M, Cerutti P. Geographic variation of p53 mutational profile in nonmalignant human liver. Science 1994;264:1317-9.
22. Oda T, Tsuda H, Scarpa A, Sakomoto M, Hirohashi S. p53 gene mutation spectrum in hepatocellular carcinoma. Cancer Res 1992;52:6358-64.
23. Kress S, Jahn UR, Bannasch P, Schwarz M. p53 mutations in hapatocellular carcinoma from Germany. Cancer Res 1992; 52:3220-3.
24. Kazachkov Y, Khaoustov V, Yoffe B, Solomon H, Klintmalm GBG, Tabor E. p53 abnormalities in hepatocellular carcinoma from United States patients: analysis of all 11 exons. Carcinogenesis 1996;17:2207-12.
25. Sarin SK, Chari S, Sundarum KR, Ahuja RK, Anand BS, Broor SL. Young v/s adult cirrhotic colon: a perspective comparitive analysis of the clinical profile, natural cause at survival. Gut 1988;29:101-7.
26. Sarin SK, Guptan RC, Banerjee K, Khandekar P. 1993 Prevelance of hepatitis B and C virus infection in patients with non-alcoholic liver disease in India. Ind J Gastroentrol 1988; 12A:107-10.
27. The Prevention Food Adulteration Act 1954 (370 of 1954 as amended up to act 70 of 1986). Lucknow, India: Estern Book Publishing Co., 69-69F.
28. Bilgrami KS. Scenario of aflatoxin contamination in India: surveillance, prevention and control of food contaminants. In: Toteja GH, Diwakar S, Saxena BN, editors. Proceedings of National Symposium. New Delhi: Indian Council of Medical Research, 1996:107-18.
29. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954; 7:462-503.
30. Das BC, Sharma JK, Gopalkrishna V, Das DK, Singh V, Gissmann L, et al. A high frequency of human papillomavirus DNA sequences in cervical carcinomas of Indian women as revealed by Southern blot hybridization and polymerase chain reaction. J Med Virol 1992;36:239-45.
31. Hayward NK, Walker GJ. Hepatocellular carcinoma mutation. Nature 1991;352:64.
32. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain termination inhbitors. Proc Natl Acad Sci USA 1977; 74:5433-67.
33. Lugassy C, Bernuau J, Theirs V Krosgaard K, Degott C, Wantzin P, et al. Sequences of hepatitis B virus DNA in the serum and liver of patients with acute benign and fulminant hepatitis. J Infect Dis 1987;155:64-9.
34. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98:503-18.
35. Das BC, Sharma IK, Gopalkrishna V, Luthra UK. Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 in cervical preneoplastic and neoplastic lesions. J Gen Virol 1992;73:2327-36.
36. Harris CC. p53: at crossroads of molecular carcinogenesis and risk assessment. Science 1993;262:1980-1.
37. 1 in nonhuman primates. Cancer Res 1992;52: 1044-6.
38. Vesey DA, Hayward NK, Cooksly WGE. p53 gene in hepatocellular carcinomas from Australia. Cancer Detect Prev 1992;18:123-30.
39. Hosono S, Lee CS, Chou MJ, Yang CS, Shih C. Molecular analysis of the p53 alleles in primary hepatocellular carcinomas and cell lines. Oncogene 1991;6:237-43.
40. Hollstein MC, Wild CP, Bleicher F, Chutimatawin S, Harris CC, Sivatanakul P, et al. p53 mutation and aflatoxin B1 exposure in hepatocellular carcinoma patients from Thailand. Int J Cancer 1993;53:51-5.
41. Bock LM, Ceruttin P. Aflatoxin B1 induces the transversions of G to T in codon 249 of the p53 tumour suppressor gene. Proc Natl Acad Sci USA 1998;94:8446-9.
42. Tiollais P, Pourcel C, Dejean A. The hepatitis B virus. Nature 1985;317:489-95.
43. Kiyosawa K, Sodayam T, Tanaka E, Gibo Y, Yoshikawa K, Nakano Y, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990;12:671-5.
44. Di Bisceglie, Simpsun LH, Lotze MT, Hoofnagle JH. Development of hepatocellular carcinoma among patients with chronic liver disesase due to hepatitis C viral infection. J Clin Gastroentrol 1994;19:222-6.
45. Edamoto Y, Tani M, Kurata T, Abe K. Hepatitis C and B virus infections in hepatocellular carcinoma: analysis of direct detection of viral genome in paraffin embedded tissues. Cancer 1996;77:1787-91.
46. Slagle B, Zhou YZ, Butel JS. Hepatitis B virus integration event in human chromosome commonly deleted in virus-positive hepatocellular carcinomas. Cancer Res 1991;51:285-93.
47. Rogler CE, Chisari FV. Cellular and molecular mechanisms of hepatocarcinogenesis. Semin Liver Dis 1992;12:265-78.
48. Scoresone KA, Zhou YZ, Butel JS, Slegle BL. p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinoma. Cancer Res 1992;52:1635-8.
49. Benn J, Schneider RJ. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci USA 1994;91: 10350-4.
50. Wang XW, Forrester K, Yeh H, Feitelson MA, Gu JR, Harris CC. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci USA 1994;91:2230-4.
51. Ueda H, Ullrich SJ, Ganemi JD, Kappel CA, Ngo L, Feitelson MA, et al. Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet 1995;9:41-7.
52. Neil JC, Cameron ER, Baxter EW. p53 and tumour viruses: catching the guardian off-guard. Trends Microbiol 1997;5: 115-20.
53. Natoli G, Avataggiati ML, Chirillo P, Costanzo A, Artini M, Balsano C, et al. Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator X. Mol Cell Biol 1994;14:989-98.
54. Lucito R, Schneider RJ. Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C. J Virol 1992;66:983-98.
55. Hall AJ, Wild CP. The toxicology of aflatoxins: human health. Veterinary and agricultural significance, In: Eaton DL, Groopman JD, editors. New York: Academic Press, 1994: 233-58.
56. Liu YH, Taylor J, Linko P, Lucier GW, Thompson CL. Glutathione S-tranferase mu in human lymphocyte and liver, role in modulating formation of carcinogen-derived DNA adducts. Carcinogenesis 1991;12:2269-75.
57. Mc Glynn KA, Rosvold EA, Lustbader FD, Hu Y, Clapper ML, Zhou T, et al. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proc Natl Acad Sci USA 1995; 92:2384-7.